697995005: Ipilimumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Immunomodulator\...

\Substance with immune checkpoint inhibitor mechanism of action (substance)\Cytotoxic T-lymphocyte-associated protein 4 inhibitor\Ipilimumab

\Immunosuppressant (substance)\Ipilimumab

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunosuppressant (substance)\Ipilimumab
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Ipilimumab
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Monoclonal antibody\Ipilimumab

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Ipilimumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Ipilimumab

\Biological substance (substance)\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Ipilimumab
\Biological substance (substance)\Immunologic substance (substance)\Antibody\Monoclonal antibody\Ipilimumab
\Biological substance (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Ipilimumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2968411014 Ipilimumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2968417013 Ipilimumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4841681000005116 ipilimumab da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ipilimumab	Is a	murin-humant monoklonalt IgG-antistof	false	Inferred relationship	Some
Ipilimumab	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Murine-human monoclonal immunoglobulin G antibody	false	Inferred relationship	Some
Ipilimumab	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that modifies the immune response or the functioning of the immune system.	false	Inferred relationship	Some
Ipilimumab	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Cytotoxic T-lymphocyte-associated protein 4 inhibitor	true	Inferred relationship	Some
Ipilimumab	Is a	Cytotoxic T-lymphocyte-associated protein 4 inhibitor	true	Inferred relationship	Some
Ipilimumab	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some
Ipilimumab	Is a	Monoclonal antibody	true	Inferred relationship	Some
Ipilimumab	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ipilimumab 5mg/mL solution for intravenous infusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ipilimumab	Inferred relationship	Some
Product containing ipilimumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ipilimumab	Inferred relationship	Some	1
Ipilimumab-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ipilimumab	Inferred relationship	Some	1
Ipilimumab only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ipilimumab	Inferred relationship	Some	1
Product containing only ipilimumab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ipilimumab	Inferred relationship	Some	1
Ipilimumab 5 mg/mL solution for infusion	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ipilimumab	Inferred relationship	Some	1
Ipilimumab 5 mg/mL solution for infusion	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ipilimumab	Inferred relationship	Some	1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ipilimumab	Inferred relationship	Some	1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ipilimumab	Inferred relationship	Some	1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ipilimumab	Inferred relationship	Some	1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ipilimumab	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2968411014	Ipilimumab	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2968417013	Ipilimumab (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4841681000005116	ipilimumab	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)